Aphria Inc. APHA

TLRY GRANTS INSIDERS STOCK AHEAD OF MERGER WITH APHA!

[Humanist]

Tilray is granting insiders stock ahead of the merger with aphria
 
April 22, 2021/ 7:15 am  
 
Earlier this month, we highlighted some of the insider stock grants and selling by members of the Tilray, Inc. (TLRY) team. 
 
When we published this article, we received a lot of favorable feedback on the topic and want to follow up on the story after the Canadian cannabis producer filed another Form 4 with the Securities and Exchange Commission (SEC). 
We believe the increased interest in Tilray’s insider activity is related to the pending mega-merger with Aphria, Inc. (APHA.TO) (APHA). In our initial article on the topic, we referred to the transactions as insignificant as it was a minimal amount of shares sold. 
 
The Form 4 that was filed by Tilray on April 20th is related to CEO Brendan Kennedy and was part of an incentive plan that was previously passed by the company. The filing includes a sale that was for the number of shares that needed to be withheld to satisfy the tax withholding obligations that are related to the vesting of the restricted stock units (RSUs). 
 
Later this month, Tilray will hold a special shareholder meeting to vote on the previously announced merger with Aphria. We believe the market will scrutinize any data that is released by either company ahead of the merger. For this reason, we wanted to provide more data on the insider transactions so our readers can better understand the stock grant. 
 
We will be closely following how the merger agreement advances and if you want to receive updates on the merger, please send an email to [e-mail] with the subject “Aphria and Tilray Merger” to be added to our distribution list.
 
For the fastest access to data on the merger, you can set up a free account or sign up for our free newsletter!
Share